Article Details

Albireo Pharma (NASDAQ:ALBO) Rating Increased to Strong-Buy at ValuEngine

Retrieved on: 2020-01-15 13:15:00

Tags for this article:

Click the tags to see associated articles and topics

Albireo Pharma (NASDAQ:ALBO) Rating Increased to Strong-Buy at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Man Group plc</b> now owns 192,850 shares of the biopharmaceutical company's stock valued at $3,857,000 after purchasing an additional 3,350 shares ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up